Medication Exposure and Neurodegenerative Disease Risk Across National Biobanks
Kristin Levine(National Institutes of Health), Hampton L. Leonard(National Institutes of Health), Kendall Van Keuren‐Jensen(Translational Genomics Research Institute), Sara Bandrés‐Ciga(National Institutes of Health), Emily Simmonds(UK Dementia Research Institute), Lara M. Lange(National Institute on Aging), Luigi Ferrucci(National Institute on Aging), Elvin T. Price(Virginia Commonwealth University), Alastair J. Noyce(Queen Mary University of London), Lana Sargent(National Institutes of Health), Emma N. Somerville(Montreal Neurological Institute and Hospital), Vanessa Pitz(National Institutes of Health), Hirotaka Iwaki(National Institute of Neurological Disorders and Stroke), Andrew Singleton(National Institute on Aging), Caroline Jonson(National Institutes of Health), Mike A. Nalls(Alzheimer's Association), Valentina Escott‐Price(Cardiff University)
Cited by 0
Related Papers
A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission
|Journal of Gerontology|1994|9.7k
Lower Extremity Function and Subsequent Disability: Consistency Across Studies, Predictive Models, and Value of Gait Speed Alone Compared With the Short Physical Performance Battery
|The Journals of Gerontology Series A|2000|2.9k
The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
|The Journals of Gerontology Series A|2014|2.5k
Analysis of shared heritability in common disorders of the brain
|Science|2018|2k